1. Home
  2. TRVI vs CLFD Comparison

TRVI vs CLFD Comparison

Compare TRVI & CLFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • CLFD
  • Stock Information
  • Founded
  • TRVI 2011
  • CLFD 1979
  • Country
  • TRVI United States
  • CLFD United States
  • Employees
  • TRVI N/A
  • CLFD N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • CLFD Telecommunications Equipment
  • Sector
  • TRVI Health Care
  • CLFD Utilities
  • Exchange
  • TRVI Nasdaq
  • CLFD Nasdaq
  • Market Cap
  • TRVI 725.7M
  • CLFD 608.6M
  • IPO Year
  • TRVI 2019
  • CLFD N/A
  • Fundamental
  • Price
  • TRVI $7.42
  • CLFD $32.79
  • Analyst Decision
  • TRVI Strong Buy
  • CLFD Strong Buy
  • Analyst Count
  • TRVI 9
  • CLFD 1
  • Target Price
  • TRVI $19.50
  • CLFD $50.00
  • AVG Volume (30 Days)
  • TRVI 1.8M
  • CLFD 196.3K
  • Earning Date
  • TRVI 08-07-2025
  • CLFD 08-06-2025
  • Dividend Yield
  • TRVI N/A
  • CLFD N/A
  • EPS Growth
  • TRVI N/A
  • CLFD N/A
  • EPS
  • TRVI N/A
  • CLFD 0.01
  • Revenue
  • TRVI N/A
  • CLFD $179,319,000.00
  • Revenue This Year
  • TRVI N/A
  • CLFD $10.77
  • Revenue Next Year
  • TRVI N/A
  • CLFD $14.46
  • P/E Ratio
  • TRVI N/A
  • CLFD $2,297.21
  • Revenue Growth
  • TRVI N/A
  • CLFD 5.72
  • 52 Week Low
  • TRVI $2.36
  • CLFD $23.78
  • 52 Week High
  • TRVI $8.11
  • CLFD $46.76
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 59.47
  • CLFD 27.44
  • Support Level
  • TRVI $7.08
  • CLFD $30.93
  • Resistance Level
  • TRVI $7.74
  • CLFD $44.98
  • Average True Range (ATR)
  • TRVI 0.42
  • CLFD 2.47
  • MACD
  • TRVI -0.05
  • CLFD -1.24
  • Stochastic Oscillator
  • TRVI 55.77
  • CLFD 11.75

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About CLFD Clearfield Inc.

Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a various products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has international presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.

Share on Social Networks: